Tourette syndrome

Teva

Pharma

Teva's Austedo expansion effort takes a hit with Tourette flop

Teva is counting on Austedo for growth amid challenges elsewhere, and this week, the drug failed two trials in Tourette syndrome.

Eric Sagonowsky Feb 20, 2020 10:36am

Fail sign

Neurocrine's 3rd Ingrezza flop dashes Tourette sales hopes

Dec 13, 2018 11:15am

Austedo

Docs like new movement-disorder meds from Neurocrine, Teva

Oct 11, 2017 7:16am

Neurocrine's Ingrezza stalls with Tourette study miss

May 24, 2017 9:34am